251 related articles for article (PubMed ID: 12730142)
1. Safety and tolerability of linezolid.
French G
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii45-53. PubMed ID: 12730142
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of linezolid in children.
Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
[TBL] [Abstract][Full Text] [Related]
3. Hematologic effects of linezolid in young children.
Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
[TBL] [Abstract][Full Text] [Related]
4. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
6. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
Ament PW; Jamshed N; Horne JP
Am Fam Physician; 2002 Feb; 65(4):663-70. PubMed ID: 11871684
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y
J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363
[TBL] [Abstract][Full Text] [Related]
8. [Case report: severe thrombocytopenia].
Sakka SG; Schürmann A; Knüttgen D; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
[TBL] [Abstract][Full Text] [Related]
9. Update on the safety of linezolid.
Metaxas EI; Falagas ME
Expert Opin Drug Saf; 2009 Jul; 8(4):485-91. PubMed ID: 19538105
[TBL] [Abstract][Full Text] [Related]
10. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
[TBL] [Abstract][Full Text] [Related]
11. Linezolid-associated thrombocytopenia.
Lam S
Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
[TBL] [Abstract][Full Text] [Related]
12. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
13. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
[TBL] [Abstract][Full Text] [Related]
14. Serotonin toxicity associated with concomitant use of linezolid.
Bergeron L; Boulé M; Perreault S
Ann Pharmacother; 2005 May; 39(5):956-61. PubMed ID: 15827071
[TBL] [Abstract][Full Text] [Related]
15. [Sideroblastic anemia after prolonged linezolid therapy].
Kakimoto T; Nakazato T; Miura R; Kurai H; Yamashita D; Sagara Y; Ishida A
Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
[TBL] [Abstract][Full Text] [Related]
16. Use of linezolid in children. Introduction.
Kaplan SL
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S151-2. PubMed ID: 14520139
[No Abstract] [Full Text] [Related]
17. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
[TBL] [Abstract][Full Text] [Related]
18. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
19. [Linezolid].
Yanagihara K; Yanagihara K; Kohno S
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():352-9. PubMed ID: 17455645
[No Abstract] [Full Text] [Related]
20. Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.
Ferry T; Ponceau B; Simon M; Issartel B; Petiot P; Boibieux A; Biron F; Chidiac C; Peyramond D
Infection; 2005 Jun; 33(3):151-4. PubMed ID: 15940417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
